AVENIO Tumor Tissue Targeted Kit V2
Product TypeAssay Kit
TechnologyNext-Generation Sequencing
Regulatory StatusRUO
Key takeaways
AVENIO Tumor Tissue Targeted Kit V2 is a product in the Sequencing & Genomics category, manufactured by Roche Diagnostics. Listed regulatory status: RUO (as reported by the manufacturer).
- Platform: Next-Generation Sequencing
- Applications: Oncology Markers

Classification
- Category
- Sequencing & Genomics
- Product Type
- Assay Kit
- Technology
- Next-Generation Sequencing
Application
- Application Area
- Oncology Markers
Regulatory Status
RUO
Reported from manufacturer sources and not independently verified.
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
The AVENIO Tumor Tissue Targeted Kit V2 is a next-generation sequencing (NGS) research use only assay for genomic profiling of solid tumors from formalin-fixed paraffin-embedded (FFPE) tissue samples.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-26
2026-10-31
availability varies
